Drug Profile
ZS 08
Alternative Names: Insulin analogue - Zensun; ZS08Latest Information Update: 11 Sep 2023
Price :
$50
*
At a glance
- Originator Zensun (Shanghai) Sci & Tech
- Class Antihyperglycaemics; Peptides
- Mechanism of Action Insulin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 11 Sep 2023 Discontinued - Preclinical for Diabetes mellitus in China (unspecified route)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Diabetes-mellitus in China
- 20 Jul 2016 Preclinical trials in Diabetes mellitus in China (unspecified route) (Zensun pipeline, July 2016)